NFKB1 and prostate carcinoma: Shanmugam et al. reported that parthenolide inhibits NF-κB at concentrations of 4–5 μM in 22Rv1 prostate cancer cells and HUVEC cells, affecting genes involved in apoptosis and cell proliferation [62].